JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway

作者：Yaru Lu, Qian Ma, Lu Yu, Huan Huang, Xiaoxi Liu, Xiaoxi Liu, Pei Chen, Hao Ran, Weibin Liu · 发表于：International Immunopharmacology · 年份：2023 · DOI：10.1016/j.intimp.2023.109693 · 被引用次数：28 · 研究领域：Myasthenia Gravis and Thymoma、Adrenal Hormones and Disorders、Psoriasis: Treatment and Pathogenesis